Thank you for your continued efforts to help us end Alzheimer’s disease by being a valued member of the Alzheimer’s Prevention Registry.
Today, we made another great step in the fight against Alzheimer’s disease. Our organization, Banner Alzheimer’s Institute, was honored to receive a $33.2M grant from the National Institutes of Health (NIH) to conduct a major prevention trial. This study, when launched, will evaluate a treatment for this disease in healthy adults, age 60-75, with the highest known genetic risk for developing Alzheimer’s in later life. It is the largest federal grant to date to test a drug specifically designed to prevent Alzheimer’s in people without symptoms.
We are now looking at potential treatments to prevent both the early and late onset forms of the disease. This kind of comprehensive approach could prove to be the tipping point in our long, arduous effort to find a way to end this devastating disease.
Enrollment in the Registry is critically important since this study will draw participants from our members. We encourage you to share this exciting news with family and friends so they too can be part of our fight to end Alzheimer’s and save precious memories. A copy of the official announcement can be found on our website, endALZnow.org/news .
Jessica Langbaum, PhD
Alzheimer's Prevention Initiative
|Remember to follow us on Facebook and Twitter!|